Forte Biosciences Inc (FBRX)
0.7275
+0.01
(+1.88%)
USD |
NASDAQ |
May 06, 16:00
0.7251
0.00 (0.00%)
Pre-Market: 20:00
Forte Biosciences Net Income (TTM): -31.48M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -31.48M |
| September 30, 2023 | -30.48M |
| June 30, 2023 | -23.93M |
| March 31, 2023 | -18.06M |
| December 31, 2022 | -13.88M |
| September 30, 2022 | -12.34M |
| June 30, 2022 | -16.69M |
| March 31, 2022 | -19.47M |
| Date | Value |
|---|---|
| December 31, 2021 | -21.71M |
| September 30, 2021 | -22.94M |
| June 30, 2021 | -20.29M |
| March 31, 2021 | -49.24M |
| December 31, 2020 | -46.49M |
| September 30, 2020 | -42.60M |
| June 30, 2020 | -38.13M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-49.24M
Minimum
Mar 2021
-12.34M
Maximum
Sep 2022
-27.18M
Average
-22.94M
Median
Sep 2021
Net Income (TTM) Benchmarks
| CEL-SCI Corp | -31.05M |
| AIM ImmunoTech Inc | -28.96M |
| IGC Pharma Inc | -14.14M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Protalix BioTherapeutics Inc | 8.312M |